The chemopreventive properties of soy isoflavonoids in animal models of breast cancer

Breast Cancer Research and Treatment

Volumn 46, Issue 2-3, 1997, Pages 169-179

  Barnes, Stephen ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Breast cancer; Estrogen effects; Genistein; Isoflavonoids; Rodent models

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; GENISTEIN; ISOFLAVONOID; SOYBEAN PROTEIN;

ANIMAL MODEL; BREAST CANCER; CANCER MODEL; CELL PROLIFERATION; CHEMOPROPHYLAXIS; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; REVIEW; TUMOR XENOGRAFT;

ANIMALS; ANTICARCINOGENIC AGENTS; DISEASE MODELS, ANIMAL; FEMALE; ISOFLAVONES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; RATS; SOYBEANS;

EID: 0031445284     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005956326155     Document Type: Review

References (71)

1. Messina M, Persky V, Setchell KDR, Barnes S: Soy intake and cancer risk: A review of in vitro and in vivo data. Nutr Cancer 21:113-131, 1994
2. Hawrylewicz EJ, Zapata JJ, Blair WH: Soy and experimental cancer: animal studies. J Nutr 125 (3 Suppl):698S-708S, 1995
3. Barnes S: Effects of genistein in in vivo and in vitro models of cancer growth. J Nutr 125:777S-783S, 1995
4. Russo J, Russo IH: Mammary gland neoplasia in long-term rodent studies [review]. Environ Hlth Perspect 104:938-967, 1996
5. Clarke R: Animal models of breast cancer. Their diversity and role in biomedical research. Breast Cancer Res Treat 39:1-6, 1996
6. Feinleib M: Setting and monitoring health objectives for the nation. Public Health Reviews 23:127-138, 1995
7. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet RA, Doody LA, Malone WF, Hawk ET, Sigman CC: New agents for cancer chemoprevention. J Cell Biochem (Suppl 26):1-28, 1996
8. Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, Covey JM, Doody LA, Omenn GS, Greenwald P, Hong WK, Parkinson DR, Bagheri D, Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, Johnson K, Knapp GG, Longfellow DG, Malone WF, Nayfield SG, Seifried HE, Swall LM, Sigman CC: Strategy and planning for chemopreventive drug development - clinical development plans II. J Cell Biochem (Suppl 26):54-71, 1996
9. Potter JD, Steinmetz K: Vegetables, fruit and phytoestrogens as preventive agents. IARC Sci Publ (139):61-90, 1996
10. Greenwald P: Principles of cancer prevention: diet and nutrition. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology, 3rd Edition. JB Lippincott, Philadelphia, 1989, pp 167-180
11. Dunn JE: Cancer epidemiology in populations of the United States - with emphasis on Hawaii and California - and Japan. Cancer Res 35:3240-3245, 1975
12. Gray GE, Pike MC, Henderson BE: Breast cancer incidence and mortality rates in different countries in relation to known factors and dietary practice. Br J Cancer 39:1-7, 1979
13. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM: Cancer of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 63:963-966, 1991
14. Willett WC, Hunter DJ, Stampfer MJ, Colditz GA, Manson JE, Spiegelman D, Rosner BA, Hennekens CH, Speizer FE: Dietary fat and fiber in relation to the risk of breast cancer. JAMA 268:2037-2044, 1992
15. Severson RK, Nomura AM, Grove JS, Stemmermann GN: A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49:1857-1860, 1989
16. Wu AH, Ziegler RG, Horn-Ross PL, Nomura AM, West DW, Kolonel LN, Rosenthal JF, Hoover RN, Pike MC: Tofu and risk of breast cancer in Asian-Americans. Cancer Epidem Biomark Preven 5:901-906, 1996
17. Troll W, Wiesner R, Shellabarger C, Holtsman S, Stone JP: Soybean diet lowers breast tumor incidence in irradiated rats. Carcinogenesis 1:469-472, 1980
18. Barnes S, Grubbs C, Setchell KDR, Carlson J: Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res 347:239-253, 1990
19. Barnes S, Peterson G, Grubbs C, Setchell K: Potential role of dietary isoflavones in the prevention of cancer. Adv Exp Med Biol 354:135-147, 1994
20. Hawrylewicz EJ, Huang HH, Blair WH: Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr 121: 1693-1698, 1991
21. Messina M, Barnes S: Workshop report from the Division of Cancer Etiology, National Cancer Institute, National Institutes of Health. The role of soy products in reducing risks of certain cancers. J Natl Cancer Inst 83:541-546, 1991
22. Kennedy AR: The evidence for soybean products as cancer preventive agents. J Nutr 125:733S-743S, 1995
23. Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, Juliana M, Whitaker LM, Kelloff GJ, Steele VE, Lubet RA: Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17:1305-1311, 1996
24. Fujita Y, Yamane T, Tanaka M, Kuwata K, Okuzumi J, et al: Inhibitory effect of (-) epigallocatechin gallate on carcinogenesis with N-ethyl-N′-nitro-N′-nitrosoguanidine in mouse duodenum. Jpn J Cancer Res 80:503-505, 1989
25. So FV, Guthrie N, Chambers AF, Moussa M, Carroll KK: Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 26:167-181, 1996
26. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S-I, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595, 1987
27. Barnes S, Peterson TG, Coward L: Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem Suppl 22:181-187, 1995
28. Coward L, Barnes NC, Setchell KDR, Barnes S: The antitumor isoflavones, genistein and daidzein, in soybean foods of American and Asian diets. J Agric Food Chem 41:1961-1967, 1993
29. Barnes S, Kirk M, Coward L: Isoflavones and their conjugates in soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J Agric Food Chem 42:2466-2474, 1994
30. Wong E: The isoflavonoids. In: Harborne JB, Mabry TJ (eds) The Flavonoids. Chapman and Hall, London, 1975, pp 743-800
31. Wahala K, Hase T, Adlercreutz H: Synthesis and labeling of isoflavone phytoestrogens, including daidzein and genistein. Proc Soc Exp Biol Med 208:27-32, 1995
32. Lamartiniere CA, Moore J, Holland M, Barnes S: Genistein and chemoprevention of breast cancer. Proc Soc Exp Biol Med 208:120-123, 1995
33. Lamartiniere CA, Moore JB, Brown NA, Thompson RA, Hardin MJ, Barnes S: Genistein suppresses mammary cancer in rats. Carcinogenesis 16:2833-2840, 1995
34. Murrill WB, Brown NM, Zhang J-X, Manzolillo PA, Barnes S, Lamartiniere CA: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17:1451-1457, 1996
35. Constantinou AI, Mehta RG, Vaughan A: Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res 16:3293-3298, 1996
36. Helferich WG: Paradoxical effects of the soy phytoestrogen genistein on growth of human breast cancer cells in vitro and in vivo. Am J Clin Nutr, in press
37. Kokoska SM, Hardin JM, Grubbs CJ, Hsu C: The statistical analysis of cancer inhibition/promotion experiments. Anticancer Research. 13:1357-1363, 1993
38. Barnes S, Coward L, Kirk M: HPLC-mass spectrometry analysis of isoflavones. Proc Soc Exp Biol Med, in press, 1997
39. Brown NM, Lamartiniere CA: Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Environ Health Persp 103:708-713, 1995
40. Grubbs CJ, Farnell DR, Hill DL, McDonough KC: Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone. J Natl Cancer Inst 74:927-931, 1985
41. Colditz GA, Frazier AL: Models of breast cancer show that risk is set by events of early life: prevention efforts must switch focus. Cancer Epidem Biomarker Prevent 4:567-571, 1995
42. Pike MC, Krailo M, Henderson B, Casagrande J, Hoel D: Hormonal risk factors, breast tissue age and the age-incidence of breast cancer. Nature (London) 303:767-770, 1983
43. Peeters PH, Verbeek AL, Krol A, Matthyssen MM, de Waard F: Age at menarche and breast cancer risk in nulliparous women. Breast Cancer Res Treatment 33:55-61, 1995
44. Rosner B, Colditz GA, Willett WC: Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am J Epidemiol 139:819-835, 1994
45. Russo J, Russo IH: The etiopathogenesis of breast cancer prevention. Cancer Letters 90:81-89, 1995
46. Zava DT, Duwe G: Estrogenic and antiproliferative properties of genistein and other isoflavonoids in human breast cancer cells in vitro. Nutr Cancer 27:31-40, 1997
47. Wang TTY, Sathyamoorthy, Phang JM: Molecular effects of genistein on estrogen receptor-mediated pathways. Carcinogenesis 17:271-275, 1996
48. Peterson TG, Barnes S: Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 179:661-667, 1991
49. Peterson TG, Barnes S: Genistein inhibits both estrogen and growth factor stimulated proliferation of human breast cancer cells. Cell Growth Diff 7:1345-1351, 1996
50. Couse JF, Curtis SW, Washburn TF, Lindzey J, Golding TS, Lubahn DB, Smithies O, Korach KS: Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocr 9:1441-1454, 1995
51. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR Jr, Lubahn DB, O'Donnell TF Jr, Korach KS, Mendelsohn ME: Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nature Medicine 3:545-548, 1997
52. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB, Couse JF, Curtis SW, Korach KS: Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 99:2429-2437, 1997
53. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930, 1996
54. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870, 1997
55. Tremblay GB, Tremblay A, Copeland NG, Gilbert DJ, Jenkins NA, Labrie F, Giguere V: Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. Mol Endocr 11: 353-365, 1997
56. Peterson TG, Barnes S: Isoflavones inhibit the growth of human prostate cancer cell lines without inhibiting epidermal growth factor receptor autophosphorylation. Prostate 22:335-345, 1993
57. Dalu A, Haskell J, Lamartiniere CA: Dietary genistein inhibits protein tyrosine phosphorylation in the dorsolateral prostate of the rat. Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Brussels, Belgium, Sept 15-18, 1996
58. Barnes S, Peterson TG: Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med 208:103-108, 1995
59. Peterson TG: Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 125:784S-789S, 1995
60. Kondo K, Tsuneizumi K, Watanabe T, Oishi M: Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases. Cancer Res 51:5398-5404, 1991
61. Rauth S, Kichina J, Green A: Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: chemosensitivity is regulated by cellular p53. Br J Cancer 75:1559-1566, 1997
62. Wei H, Bowen R, Cai Q, Barnes S, Wang Y: Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208: 124-130, 1995
63. Wei H, Barnes S, Wang Y: Inhibitory effect of genistein on a tumor promotor-induced c-fos and c-jun expression in mouse skin. Oncol Report 3:125-128, 1996
64. Kim H, Peterson TG, Barnes S: Mechanisms of action of the soy isoflavone genistein: emerging role of its effects through transforming growth factor beta signaling pathways. Am J Clin Nutr, accepted for publication
65. Ip C, Ganther HE: Combination of blocking agents and suppressing agents in cancer prevention. Carcinogenesis 12:365-367, 1991
66. Barnes S, Sfakianos J, Coward L, Kirk M, Peterson TG: Soy isoflavonoids and cancer prevention: underlying biochemical and pharmacological issues. In: Butrum R (ed) Dietary Phytochemicals and Cancer Prevention. Plenum Press, New York, 1996, pp 87-100
67. Hodgson JM, Croft KD, Puddey IB, Mori TA, Beilin LJ: Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum. J Nutr Biochem 7:664-669, 1996
68. Dwivedi C, Zhang Y, Jensen HJ, Singh KK: Effects of genistein on skin tumor development in mice. Biochem Arch 12:273-276, 1996
69. DeClerck YA, Imren S: Protease inhibitors: role and potential therapeutic use in human cancer. Eur J Cancer 30A:2170-2180, 1994
70. Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L: Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 125(3 Suppl):790S-797S, 1995
71. Kruse FE, Joussen AM, Fotsis T, Schweigerer L, Rohrschneider K, Volcker HE: Inhibition of neovascularization of the eye by dietary factors exemplified by isoflavonoids. Ophthalmologie 94:152-156, 1997